AKRINOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Akrinol, and when can generic versions of Akrinol launch?
Akrinol is a drug marketed by Schering and is included in one NDA.
The generic ingredient in AKRINOL is acrisorcin. Additional details are available on the acrisorcin profile page.
Summary for AKRINOL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 17 |
Patent Applications: | 979 |
DailyMed Link: | AKRINOL at DailyMed |
US Patents and Regulatory Information for AKRINOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Schering | AKRINOL | acrisorcin | CREAM;TOPICAL | 012470-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |